Dissecting outcomes of patients (pts) with <ypT2N0 disease after neoadjuvant chemotherapy (NAC) for muscle invasive bladder cancer (MIBC): Results from a large, international, multicenter collaboration.

Authors

Praful Ravi

Praful Ravi

Dana-Farber Cancer Institute, Boston, MA

Praful Ravi , Gregory Russell Pond , Leonidas Nikolaos Diamantopoulos , Rohit K. Jain , William Paul Skelton IV, Sumati Gupta , Jonathan David Tward , Kathleen Olson , Parminder Singh , Camilla Marisa Grunewald , Guenter Niegisch , Jae-Lyun Lee , Andrea Gallina , Marco Bandini , Andrea Necchi , Matthew Mossanen , Bradley Alexander McGregor , Catherine Curran , Petros Grivas , Guru Sonpavde

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Bladder Cancer

Citation

J Clin Oncol 38: 2020 (suppl; abstr 5043)

DOI

10.1200/JCO.2020.38.15_suppl.5043

Abstract #

5043

Poster Bd #

112

Abstract Disclosures